Laporan Laba Rugi (TTM)
Laporan Laba Rugi Alexandria Co. For Pharmaceuticals & Chemical Industries menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.
Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.
|
2020 09-30 |
2020 12-31 |
2021 03-31 |
2021 06-30 |
2021 09-30 |
2021 12-31 |
2022 03-31 |
2022 06-30 |
2022 09-30 |
2023 06-30 |
2023 09-30 |
2024 06-30 |
2024 09-30 |
2024 12-31 |
2025 03-31 |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1,073 | 1,074 | 1,116 | 1,104 | 1,095 | 1,108 | 1,063 | 1,100 | 1,154 | 1,484 | 1,628 | 1,768 | 2,062 | 2,331 | 2,308 |
| Change (%) | 0.03 | 3.91 | -1.02 | -0.86 | 1.17 | -4.03 | 3.49 | 4.94 | 28.59 | 9.67 | 8.62 | 16.61 | 13.09 | -0.99 | |
| % of Revenue | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 |
| Cost Of Sales | 736 | 760 | 830 | 841 | 851 | 872 | 842 | 877 | 920 | 1,223 | 1,335 | 1,373 | 1,588 | 1,810 | 1,777 |
| Change (%) | 3.19 | 9.17 | 1.44 | 1.11 | 2.55 | -3.43 | 4.07 | 4.88 | 33.05 | 9.13 | 2.83 | 15.67 | 14.01 | -1.88 | |
| % of Revenue | 68.61 | 70.78 | 74.36 | 76.20 | 77.71 | 78.77 | 79.26 | 79.71 | 79.66 | 82.42 | 82.02 | 77.65 | 77.03 | 77.65 | 76.96 |
| Gross Operating Profit | 337 | 314 | 286 | 263 | 244 | 235 | 220 | 223 | 235 | 261 | 293 | 395 | 474 | 521 | 532 |
| Change (%) | -6.87 | -8.82 | -8.14 | -7.16 | -3.63 | -6.26 | 1.28 | 5.18 | 11.11 | 12.18 | 35.03 | 19.85 | 10.00 | 2.10 | |
| % of Revenue | 31.39 | 29.22 | 25.64 | 23.80 | 22.29 | 21.23 | 20.74 | 20.29 | 20.34 | 17.58 | 17.98 | 22.35 | 22.97 | 22.35 | 23.04 |
| SG&A | 91 | 87 | 91 | 94 | 88 | 87 | 83 | 76 | 78 | 84 | 33 | 89 | 146 | 100 | 98 |
| Change (%) | -3.76 | 4.35 | 3.02 | -6.21 | -1.47 | -4.56 | -8.47 | 2.74 | 7.46 | -60.47 | 169.68 | 63.46 | -31.35 | -2.18 | |
| % of Revenue | 8.44 | 8.12 | 8.15 | 8.49 | 8.03 | 7.82 | 7.78 | 6.88 | 6.73 | 5.63 | 2.03 | 5.04 | 7.06 | 4.29 | 4.23 |
| R&D | |||||||||||||||
| Change (%) | |||||||||||||||
| % of Revenue | |||||||||||||||
| OpEx | 830 | 856 | 925 | 950 | 960 | 978 | 944 | 965 | 1,012 | 1,329 | 1,443 | 1,501 | 1,723 | 1,947 | 1,910 |
| Change (%) | 3.12 | 8.07 | 2.69 | 1.06 | 1.84 | -3.46 | 2.27 | 4.80 | 31.39 | 8.56 | 3.97 | 14.85 | 13.00 | -1.93 | |
| % of Revenue | 77.36 | 79.75 | 82.94 | 86.04 | 87.71 | 88.28 | 88.81 | 87.77 | 87.65 | 89.56 | 88.66 | 84.87 | 83.59 | 83.53 | 82.74 |
| Operating Income | 243 | 217 | 190 | 154 | 135 | 130 | 119 | 135 | 143 | 155 | 185 | 267 | 338 | 384 | 398 |
| Change (%) | -10.53 | -12.44 | -19.03 | -12.66 | -3.59 | -8.38 | 13.16 | 5.95 | 8.69 | 19.15 | 44.91 | 26.46 | 13.52 | 3.77 | |
| % of Revenue | 22.64 | 20.25 | 17.06 | 13.96 | 12.29 | 11.72 | 11.19 | 12.23 | 12.35 | 10.44 | 11.34 | 15.13 | 16.41 | 16.47 | 17.26 |
| Interest Expense | -1 | -2 | |||||||||||||
| Change (%) | 180.23 | ||||||||||||||
| % of Revenue | -0.05 | -0.14 | |||||||||||||
| Net Income | 177 | 164 | 144 | 117 | 101 | 95 | 89 | 117 | 123 | 126 | 151 | 217 | 271 | 306 | 308 |
| Change (%) | -7.53 | -12.17 | -18.67 | -13.92 | -5.36 | -6.43 | 31.67 | 5.05 | 2.50 | 19.45 | 43.48 | 25.10 | 12.88 | 0.51 | |
| % of Revenue | 16.50 | 15.26 | 12.89 | 10.60 | 9.20 | 8.61 | 8.39 | 10.67 | 10.69 | 8.52 | 9.28 | 12.26 | 13.15 | 13.12 | 13.32 |
Source: Capital IQ
